Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 to 85

Comparing treatments for inflammation in patients with eye prostheses

Official title: Comparison of Topical Hydrocortisone Versus Dexamethasone Treatment for Inflammatory Secretions of the Conjonctiva in Patients With Ocular Prostheses

Run by Rennes University Hospital · NCT05668455 · Data updated 2026-11-12

This study is testing whether Hydrocortisone or Dexamethasone can help reduce inflammation and discomfort in people who wear eye prostheses.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment30 (estimated)
SponsorRennes University Hospital
Academic / other
Locations1 site (Rennes)
StatusRecruiting
StartedMay 12, 2023
Main results expectedDecember 25, 2025
Study endsJuly 20, 2026
Registry record updatedAugust 15, 2025
Trial IDNCT05668455 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have been wearing a permanent ocular prosthesis for more than six months and experience significant functional discomfort.

Probably not a fit

Patients who have recently used other eye drops or have specific contraindications to the study treatments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of Hydrocortisone and Dexamethasone in treating ocular inflammation in patients who wear ocular prostheses. It will utilize a prospective, placebo-controlled, single-blind design to assess the impact of these anti-inflammatory treatments on patients experiencing significant discomfort. The study builds on previous findings from a pilot study that suggested Dexamethasone may be beneficial, but seeks to provide more rigorous evidence through a controlled methodology.

Why it matters

Potential benefit: If successful, this study could significantly improve the quality of life for patients with ocular prostheses by reducing inflammation and discomfort.

How similar studies have gone: Previous studies have shown some promise with Dexamethasone in similar patient populations, but this study aims to provide more definitive evidence through a controlled approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged 18 years or older;
* Wearing a permanent prosthesis for more than 6 months; - Consultant in the ophthalmology department;
* Modified OSDI score ≥ 20 points out of 40 ;
* Affiliated with a health insurance scheme,
* For women of childbearing age: effective contraception (effective contraception includes oral contraception, intrauterine devices and other forms of contraception with a failure rate \<1%, for the duration of the study and up to 1 week after the last dose administered)
* Have given free, informed and written consent.

Exclusion Criteria:

* Treatment with eye drop(s) (other than artificial tears or antiseptic) \< 1 month;
* Concomitant treatment with CYP3A inhibitors including cobicistat containing drugs,
* Known contraindications to study treatments
* Dermal fat grafting or complicated cavity;
* Gougerot-Sjögren syndrome;
* Allergic conjunctivitis;
* Damaged prosthesis;
* Impossibility of carrying out the various tests required by the protocol for whatever reason (comprehension problems, motor disability);
* Pregnant or breastfeeding woman;
* Person already included in a RIPH1 research protocol with topical treatment of the cavity or systemic anti-inflammatory treatment and/or who could lead to a bias in the present study
* Person under legal protection (safeguard of justice, curatorship, guardianship) or person deprived of liberty.

Where it's running

  • Centre Hospitalier Universitaire de Rennes _ Pontchaillou
    Rennes, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.